findmyKOL
Clinical trialNCT04545047CompletedObservational

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

SponsorVA Office of Research and DevelopmentEnrollment5,044Coronavirus Disease 2019 (COVID-19)
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to assess whether convalescent plasma therapy is associated with reduced 30-day all-cause mortality in a population of Veteran inpatients with non-severe coronavirus disease 2019 (COVID-19).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Michael J Gaziano, MD MPH

    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA

    Study Chair
  • Nicholas L. Smith, PhD

    VA Puget Sound Health Care System Seattle Division, Seattle, WA

    Study Chair

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Va Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, Ma

    Boston, Massachusetts, United States

  • Va Puget Sound Health Care System Seattle Division, Seattle, Wa

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

COVID-19 convalescent plasma
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2020
Primary completion
1 Oct 2021
Completion
1 Oct 2021
Last update posted
4 Apr 2024
Registered enrollment
5,044
Registry id
NCT04545047

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.